Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Treatments and drugs

By Mayo Clinic staff

Treatment of Brugada syndrome depends on the risk of an abnormal heartbeat (arrhythmia). Those considered at high risk have:

  • A family history of sudden cardiac death
  • A personal history of serious heart rhythm problems
  • A personal history of severe fainting spells

Because of the nature of the heart rhythm abnormality, medications can't treat Brugada syndrome — only a medical device called an implantable cardioverter-defibrillator can. Implanting the device is usually recommended for people at high risk of sudden cardiac death or other complications of Brugada syndrome.

  • Implantable cardioverter-defibrillator (ICD). For high-risk individuals, treatment may include an implantable cardioverter-defibrillator (ICD). This small device continuously monitors your heart rhythm and delivers electrical shocks when needed to control abnormal heartbeats. The procedure to implant an ICD requires hospitalization for a day or two.

    There's a risk of complications from having an ICD implanted. People who have an ICD implanted as a treatment for Brugada syndrome have reported receiving shocks from their ICD even when their heartbeat was regular. This may be because many people who receive an ICD as a treatment for Brugada syndrome are young, and may receive shocks when their heart rates increase during normal stresses, such as exercise. Your doctor will program your ICD to reduce this risk. If you have an ICD implanted as part of your Brugada syndrome treatment, talk to your doctor about ways to avoid inappropriate shocks.

References
  1. Wylie JV, et al. Brugada syndrome and sudden cardiac arrest. http://www.uptodate.com/home/index.html. Accessed March 24, 2008.
  2. Benito B, et al. Brugada syndrome. Progress in Cardiovascular Diseases. 2008;51:1.
  3. Benito B, et al. Gender differences in clinical manifestations of Brugada syndrome. Journal of the American College of Cardiology. 2008;52:1567.
  4. Antzelevitch C, et al. Brugada syndrome: Recent advances and controversies. Current Cardiology Reports. 2008;10:376.
  5. The Brugada syndrome. Ramon Brugada Senior Foundation. http://www.brugada.org/about/about.html. Accessed April 14, 2009.

DS01142

May 29, 2009

© 1998-2010 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger